PHARMA.AERO, the IATA CEIV-based collaboration for shippers and air cargo industry stakeholders, has welcomed Turkish Cargo and global ground handler WFS by presenting them with membership certificates at the Air Cargo Forum earlier this month.
Speaking at the forum, Phama.Aero secretary general Frank van Gelder outlined the organisation's progress - described by IATA cargo head Glyn Hughes as a 'phenomenal achievement in such a short time.'
Over six workshops conducted last year by the industry and pharma shippers, the participants evaluated the extensive CEIV checklist, reviewed the audit methodology and priorities, identified challenges, developed and validated an audit checklist and finally discussed technical issues with IATA and agreed next steps, reported London's Freightweek.
Mr Van Gelder said all pharma shippers had committed to validate CEIV certification provided IATA integrates their feedback into the methodology.
He also outlined what the participants had concluded so far: simplified audit process with certified suppliers not requiring additional pharma company audits.
The alignment of pharma shipper procedures with CEIV standards include more audit focus on specific airside transport providers where most temperature excursions occur; and better audit transparency on station capabilities and performance.
As a result of the Pharma.Aero initiative, major pharmaceutical companies now have a much better understanding of the CEIV process and their role as stakeholders.
Mr Van Gelder said shippers have also benefitted from the greater transparency engendered by the on-going multi-stakeholder process and the challenges faced by all parties, whether they are a trucking company, ground handler or an airline.
Speaking at the forum, Phama.Aero secretary general Frank van Gelder outlined the organisation's progress - described by IATA cargo head Glyn Hughes as a 'phenomenal achievement in such a short time.'
Over six workshops conducted last year by the industry and pharma shippers, the participants evaluated the extensive CEIV checklist, reviewed the audit methodology and priorities, identified challenges, developed and validated an audit checklist and finally discussed technical issues with IATA and agreed next steps, reported London's Freightweek.
Mr Van Gelder said all pharma shippers had committed to validate CEIV certification provided IATA integrates their feedback into the methodology.
He also outlined what the participants had concluded so far: simplified audit process with certified suppliers not requiring additional pharma company audits.
The alignment of pharma shipper procedures with CEIV standards include more audit focus on specific airside transport providers where most temperature excursions occur; and better audit transparency on station capabilities and performance.
As a result of the Pharma.Aero initiative, major pharmaceutical companies now have a much better understanding of the CEIV process and their role as stakeholders.
Mr Van Gelder said shippers have also benefitted from the greater transparency engendered by the on-going multi-stakeholder process and the challenges faced by all parties, whether they are a trucking company, ground handler or an airline.